Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
Life · 18.09.2023 · 13 (9) · 1931
DOI: 10.3390/life13091931 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 18.09.2023. Verfasst von Alexey V Churov und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute on Aging Research, Russian Gerontology Clinical Research Center, Pirogov Russian National Research Medical University, 129226 Moscow, Russi…. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Atherosclerosis is an insidious vascular disease with an asymptomatic debut and development over decades. The aetiology and pathogenesis of atherosclerosis are not completely clear. However, chronic inflammation and autoimmune reactions play a significant role in the natural course of atherosclerosis. The pathogenesis of atherosclerosis involves damage to the intima, immune cell recruitment and infiltration of cells such as monocytes/macrophages, neutrophils, and lymphocytes into the inner layer of vessel walls, and the accumulation of lipids, leading to vascular inflammation. The recruited immune cells mainly have a pro-atherogenic effect, whereas CD4+ regulatory T (Treg) cells are another heterogeneous group of cells with opposite functions that suppress the pathogenic immune responses. Present in low numbers in atherosclerotic plaques, Tregs serve a protective role, maintaining immune homeostasis and tolerance by suppressing pro-inflammatory immune cell subsets. Compelling experimental data suggest that various Treg cell-based approaches may be important in the treatment of atherosclerosis. Here we highlight the most recent advances in our understanding of the roles of FOXP3-expressing CD4+ Treg cells in the atherogenic process and discuss potential translational strategies for the treatment of atherosclerosis by Treg manipulation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute on Aging Research, Russian Gerontology Clinical Research Center, Pirogov Russian National Research Medical University, 129226 Moscow, Russia.
- Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315 Moscow, Russia.
- Moscow Aviation Institute, National Research University, 4 Volokolamskoe Shosse, 125993 Moscow, Russia.
ORCID-Profile: Alexey V Churov, Victoria A Khotina, Vladimir P Ofitserov, Alexander N Orekhov
Förderung
- Russian Science Foundation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Churov, A. V., Chegodaev, Y. S., Khotina, V. A., Ofitserov, V. P., & Orekhov, A. N. (2023). Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?. Life, 13(9), 1931. https://doi.org/10.3390/life13091931
Vancouver
Churov AV, Chegodaev YS, Khotina VA, Ofitserov VP, Orekhov AN. Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?. Life. 2023;13(9):1931. doi:10.3390/life13091931
BibTeX
@article{Churov2023,
author = {Churov, Alexey V and Chegodaev, Yegor S and Khotina, Victoria A and Ofitserov, Vladimir P and Orekhov, Alexander N},
title = {Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?},
journal = {Life},
year = {2023},
volume = {13},
number = {9},
pages = {1931},
doi = {10.3390/life13091931}
}
EUVIMED